A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease
NCT02951234 is an interventional trial sponsored by Chang Gung Memorial Hospital. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Kawasaki Disease. The registry lists an enrollment of 278 participants at 5 sites in 1 country. The registry lists a start date of 30 Sept 2016 and a primary completion date of 31 Aug 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02951234 |
| Status | Unknown |
| Study type | Interventional trial |
| Lead sponsor | Chang Gung Memorial Hospital |
| Enrollment | 278 |
| Registered sites | 5 |
| Countries | 1 |
| Conditions | Kawasaki Disease |
| Start | 30 Sept 2016 |
| Primary completion | 31 Aug 2019 |
| Study completion | 31 Aug 2019 |
| Last update posted | 6 Mar 2018 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ho-Chang Kuo, MD, PhD
Kawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City
Recruiting - Kaohsiung Veterans General Hospital
Kaohsiung City
Recruiting - Taichung Veterans General Hospital
Taichung
Recruiting - Tungs' Taichung Metroharbor Hospital
Taichung
Recruiting - Linkou Chang Gung Memorial Hospital
Taipei
Recruiting
Sites by country
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02951234
Each answer restates registry values shown on this page.
What is NCT02951234?
NCT02951234 is an interventional trial sponsored by Chang Gung Memorial Hospital. It studies Kawasaki Disease.
Who leads NCT02951234?
The registry names Ho-Chang Kuo, MD, PhD (principal investigator, Kawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital) as the overall official.
Where does NCT02951234 run?
The registry lists 5 sites in 1 country. Every site with a stated country is in one country: Taiwan.
When is NCT02951234 expected to complete?
The registry lists a primary completion date of 31 Aug 2019 and a study completion date of 31 Aug 2019. The sponsor last updated the record on 6 Mar 2018.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.